Skip to main content
TipRanks
Go Ultimate75% OFF

JOHN DEMAREE Insider Profile

4 Followers

JOHN DEMAREE, CCO at Karyopharm Therapeutics, holds 24.00K shares in Karyopharm Therapeutics (Ticker: KPTIQ), holds 5.25K shares in G1 Therapeutics (Ticker: GTHX).

JOHN DEMAREE's Trading History

KPTIQ
Karyopharm Therapeutics
Mar 01, 2021CCOUninformative Buy―$599.88
GTHX
G1 Therapeutics
Dec 11, 2018―Informative Buy33.15K$37.54K

You May Also Like

JOHN DEMAREE insider profile FAQ

What is the percentage of profitable transactions made by JOHN DEMAREE?
The percentage of profitable transactions made by JOHN DEMAREE is 0%.
What is the average return per transaction made by JOHN DEMAREE?
The average return per transaction made by JOHN DEMAREE is -45.30%.
What stocks does JOHN DEMAREE hold?
JOHN DEMAREE holds: KPTIQ, GTHX stocks.
What was JOHN DEMAREE's most profitable transaction?
JOHN DEMAREE’s most profitable transaction was an Informative Buy of GTHX stock on December 11, 2018. The return on the trade was -30.40%.
What is JOHN DEMAREE's role in Karyopharm Therapeutics?
JOHN DEMAREE's role in Karyopharm Therapeutics is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.